RUMOSPAS-10
MRP: 2,200
Packaging: 10x10
Pack Type: tablet
Composition:
Leflunomide 10mg
Indication:
Used for the treatment of rheumatoid arthritis and psoriatic arthritis to reduce inflammation, relieve symptoms, and slow disease progression.
Description:
Leflunomide 10 mg is a Disease-Modifying Anti-Rheumatic Drug (DMARD) used to treat rheumatoid arthritis and psoriatic arthritis. It works by inhibiting dihydroorotate dehydrogenase, an enzyme essential for DNA synthesis in activated T-cells, thus reducing autoimmune inflammation. The 10 mg dosage may be used for dose titration, maintenance therapy, or in patients who cannot tolerate higher doses.
Tags:
- Controls inflammation and autoimmune activity in arthritis
- Reduces joint swelling, stiffness, and pain
- Slows disease progression and joint damage
- Suitable for mild cases or those requiring dose adjustment
- Can be used in combination therapy
Usage Information
Dosage
Typical adult dose: 10 mg once daily or as directed by the physician May be used in step-down therapy or in combination with other DMARDs Swallow whole with or without food Monitoring of liver function and blood counts is recommended regularly
Side Effects
Common: Diarrhea, nausea, mild liver enzyme elevation Less common: Rash, dizziness, fatigue, mild respiratory symptoms Serious: Liver damage, bone marrow suppression, interstitial lung disease (rare)
Contraindications
Pregnancy – contraindicated due to high risk of fetal toxicity Severe liver disease History of serious infections or immune suppression Known allergy to Leflunomide or its metabolites Not recommended in breastfeeding women
Availability
Leflunomide 10mg tablet DMARD for arthritis Low dose Leflunomide Leflunomide rheumatoid arthritis treatment Leflunomide for autoimmune disease Leflunomide 10mg uses and side effects